These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12825929)

  • 1. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain.
    Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER
    J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of (17alpha,20Z)-21-(4-substituted-phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as ligands for the estrogen receptor-alpha hormone binding domain: comparison with 20E-isomers.
    Hanson RN; Friel CJ; Dilis R; Hughes A; DeSombre ER
    J Med Chem; 2005 Jun; 48(13):4300-11. PubMed ID: 15974584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of isomeric (17alpha,20E)-11beta-methoxy-21-(trifluoromethylphenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as ERalpha-hormone binding domain ligands: effect of the methoxy group on receptor binding and uterotrophic growth.
    Hanson RN; Tongcharoensirikul P; Dilis R; Hughes A; Desombre ER
    J Med Chem; 2007 Feb; 50(3):472-9. PubMed ID: 17266199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 11beta-substituted 21-chloro/iodo-(17alpha,20E/Z)-19-norpregna-1,3,5(10),20-te traene-3, 17beta-diols: high-affinity ligands for the estrogen receptor.
    Hanson RN; Napolitano E; Fiaschi R
    J Med Chem; 1998 Nov; 41(24):4686-92. PubMed ID: 9822539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W
    J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational studies on (17alpha,20Z)-21-(X-Phenyl)-19-norpregna-1, 3,5(10),20-tetraene-3,17beta-diols using 1D and 2D NMR spectroscopy and GIAO calculations of (13)C shieldings.
    Sebag AB; Friel CJ; Hanson RN; Forsyth DA
    J Org Chem; 2000 Nov; 65(23):7902-12. PubMed ID: 11073597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 17alpha-E-(trifluoromethylphenyl)vinyl estradiols as novel estrogen receptor ligands.
    Hanson RN; Lee CY; Friel C; Hughes A; DeSombre ER
    Steroids; 2003 Feb; 68(2):143-8. PubMed ID: 12606005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
    Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
    J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
    Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of estrogenic ligands: synthesis and evaluation of (17 alpha, 20E)- and (17 alpha, 20Z)-21-halo-19-norpregna-1,3,5(10),20-tetraene-3,17 beta-diols.
    Napolitano E; Fiaschi R; Hanson RN
    J Med Chem; 1991 Sep; 34(9):2754-9. PubMed ID: 1895295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of phenolic 4,5-dihydroisoxazoles and 3-hydroxy ketones as estrogen receptor alpha and beta agonists.
    Poutiainen PK; Venäläinen TA; Peräkylä M; Matilainen JM; Väisänen S; Honkakoski P; Laatikainen R; Pulkkinen JT
    Bioorg Med Chem; 2010 May; 18(10):3437-47. PubMed ID: 20430632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
    Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
    J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity.
    Kasiotis KM; Mendorou C; Haroutounian SA; Alexis MN
    Steroids; 2006 Mar; 71(3):249-55. PubMed ID: 16360721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
    Wolohan P; Reichert DE
    J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereochemical probes for the estrogen receptor: synthesis and receptor binding of (17 alpha,20E/Z)-21-phenyl-19-norpregna-1,3,5(10), 20-tetraene-3,17 beta-diols.
    Hanson RN; Herman LW; Fiaschi R; Napolitano E
    Steroids; 1996 Dec; 61(12):718-22. PubMed ID: 8987141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
    Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
    J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.